The Impact of Inherited Thrombophilia on First Trimester Combined Aneuploidy Screening Parameters

1 Karagur, E. et al. The impact of hereditary thrombophilias in recurrent pregnancy loss, Genetika, 2022, 54(3), pp. 1399-1410. doi:10.2298/gensr2203399k Search in Google Scholar

2 Karsli MF, et al. The impact of inherited thrombophilia on first trimester combined aneuploidy screening test parameters, The Journal of Maternal-Fetal & Neonatal Medicine, 2013, 27(4), pp. 346–349. doi:10.3109/14767058.2013.818123 Search in Google Scholar

3 Kirovakov Z, Gyokova E, et al. Thromboprophylaxis during pregnancy for prevention of adverse complications in patients with inherited thrombophilia: A literature review, Journal of Biomedical and Clinical Research, ɛ2024, 17(1), 115–126. doi:10.3897/jbcr.e123690 Search in Google Scholar

4 Kirovakov Z, Hinkova N, Konova E. Frequency of Thrombophilic Factors in Patients with Recurrent Pregnancy Loss, ISAR Journal of Medical and Pharmaceutical Sciences, 2024, 2(3) Search in Google Scholar

5 Kirovakov Z, Konova E, Hinkova N, Markova S. The Role of Gestational Management and use of LMWH and Aspirin in Patients with Inherited thrombophilia, ISAR Journal of Medical and Pharmaceutical Sciences, 2024, 2(3). doi:10.5281/zenodo.10791430 Search in Google Scholar

6 Linehan LA. et al. Reproductive outcomes following recurrent first-trimester miscarriage: A retrospective cohort study, Human Reproduction Open, 2022 (4) Search in Google Scholar

7 Shehata H, et al. Prevalence of thrombophilia in women with recurrent early miscarriage, and a systematic review of the literature, SSRN Electronic Journal [Preprint] 2021, doi:10.2139/ssrn.3812429 Search in Google Scholar

8 Shehata H, et al. Thrombophilia screening in women with recurrent first trimester miscarriage: Is it time to stop testing? – A cohort study and systematic review of the literature, BMJ Open, 2022, 12(7). doi:10.1136/bmjopen-2021-059519. Search in Google Scholar

9 Fabregues F, et al. The role of Thrombophilias in reproduction: A SWOT analysis, European Journal of Obstetrics & Gynecology and Reproductive Biology, 2023, 280, pp. 12–21. doi:10.1016/j.ejogrb.2022.10.024 Search in Google Scholar

10 Gojnic MG, et al. Combined hereditary thrombophilias are responsible for poor placental vascularization development and low molecular weight heparins (LMWH) prevent adverse pregnancy outcomes in these patients, The Journal of Maternal-Fetal & Neonatal Medicine, 2020, 35(22), pp. 4346–4353. doi:10.1080/14767058.2020.1849116 Search in Google Scholar

11 Grandone E, Piazza G. Thrombophilia, inflammation, and recurrent pregnancy loss: A case-based review, Seminars in Reproductive Medicine, 2021, 39(01/02), pp. 062–068. doi:10.1055/s-0041-1731827 Search in Google Scholar

12 Ahangari N, et al. Hereditary thrombophilia genetic variants in recurrent pregnancy loss, Archives of Gynecology and Obstetrics, 2019, 300(3), pp. 777–782. doi:10.1007/s00404-019-05224-7 Search in Google Scholar

13 Vomstein K, et al. Immunological risk factors in recurrent pregnancy loss: Guidelines versus current state of the art, Journal of Clinical Medicine, 2021, 10(4), p. 869. doi:10.3390/jcm10040869 Search in Google Scholar

14 Kirovakov Z, Konova E, Hinkova N, et al. Immunological risk factors in recurrent pregnancy loss in patients with hereditary thrombophilia, Cureus [Preprint] 2024, doi:10.7759/cureus.56555 Search in Google Scholar

15 Alecsandru D, et al. Immunologic causes and thrombophilia in recurrent pregnancy loss, Fertility and Sterility, 2021, 115(3), pp. 561–566. doi:10.1016/j.fertnstert.2021.01.017 Search in Google Scholar

16 Borsi E, et al. Risk factors of thrombophilia-related mutations for early and late pregnancy loss, Medicina, 2024, 60(4), p. 521. doi:10.3390/medicina60040521 Search in Google Scholar

17 Deng Y, et al. Research trends and hotspots of recurrent pregnancy loss with thrombophilia: A bibliometric analysis, BMC Pregnancy and Childbirth, 2022, 22(1). doi:10.1186/s12884-022-05210-z Search in Google Scholar

18 Han AR, Han JW, Lee SK. Inherited thrombophilia and anticoagulant therapy for women with reproductive failure, American Journal of Reproductive Immunology, 2020, 85(4). doi:10.1111/aji.13378 Search in Google Scholar

19 Iordache O, et al. A retrospective assessment of thrombophilia in pregnant women with first and second trimester pregnancy loss, International Journal of Environmental Research and Public Health, 2022, 19(24), p. 16500. doi:10.3390/ijerph192416500 Search in Google Scholar

20 Lafalla O. et al. Clinical utility of thrombophilia, anticoagulant treatment, and maternal variables as predictors of placenta-mediated pregnancy complications: An extensive analysis’, The Journal of Maternal-Fetal & Neonatal Medicine, 2019, 34(4), pp. 588–598. doi:10.1080/14767058.2019.161 1764 Search in Google Scholar

21 Wen Y, He H, Zhao K. Thrombophilic gene polymorphisms and recurrent pregnancy loss: A systematic review and meta-analysis, Journal of Assisted Reproduction and Genetics, 2023, 40(7), pp. 1533–1558. doi:10.1007/s10815-023-02823-x Search in Google Scholar

22 Yousif TY. Prevalence of inherited thrombophilia in women with recurrent pregnancy loss during the first trimester of pregnancy, Journal of Blood Medicine, 2023, Volume 14, pp. 253–259. doi:10.2147/jbm.s401469. Search in Google Scholar